Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-14987-w
Abstract: We characterized all ceftazidime-avibactam-resistant KPC-producing K. pneumoniae (KPC-Kp) isolates recovered from both patients and environmental samples at the ICU of our hospital in 2020, during the COVID-19 pandemic initiation. Antimicrobial susceptibility testing (Sensititre-EUMDROXF; disk-diffusion) and…
read more here.
Keywords:
kpc kpc;
ceftazidime avibactam;
environment;
kpc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00150-21
Abstract: KPC-82 is a KPC-2 variant identified in a carbapenem-nonsusceptible Citrobacter koseri that confers high-level resistance to ceftazidime-avibactam. Genomic analysis revealed that blaKPC-82 is carried by a chromosomally integrated Tn4401 transposon (disrupting porin gene phoE) and…
read more here.
Keywords:
citrobacter koseri;
resistance ceftazidime;
kpc variant;
kpc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Antibiotics"
DOI: 10.3390/antibiotics12020300
Abstract: Carbapenem-resistant Enterobacterales (CRE) are increasingly recognized as an urgent public health concern. The rapid and accurate identification of carbapenemases could provide insights into antimicrobial therapy and infection control. In this study, we evaluated the efficacy…
read more here.
Keywords:
kpc;
kpc kpc;
cgi test;
xpert carba ... See more keywords